References
- Lutgring JD. Carbapenem-resistant Enterobacteriaceae: an emerging bacterial threat. Semin Diagn Pathol. 2019;36(3):182–186. doi:10.1053/j.semdp.2019.04.011
- Aslam A, Gajdács M, Zin CS, et al. Evidence of the practice of self-medication with antibiotics among the lay public in low- and middle-income countries: a scoping review. Antibiotics. 2020;9(9):597. doi:10.3390/antibiotics9090597
- Nordmann P, Poirel L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis. 2019;69(Supplement_7):S521–S528. doi:10.1093/cid/ciz824
- Li Y, Sun QL, Shen Y, et al. Rapid increase in prevalence of carbapenem-resistant enterobacteriaceae (CRE) and emergence of colistin resistance gene mcr-1 in CRE in a hospital in Henan, China. J Clin Microbiol. 2018;56(4). doi:10.1128/JCM.01932-17
- Richter S, Virulence DM. Screening for carbapenem-resistant Enterobacteriaceae: who, when, and how? Taylor Fr. 2016;8(4):417–426. doi:10.1080/21505594.2016.1255381
- van Duin D. Carbapenem-resistant Enterobacteriaceae: what we know and what we need to know. Virulence. 2017;8(4):379–382. doi:10.1080/21505594.2017.1306621
- Hancock REW, Chapple DS. Peptide antibiotics. Antimicrob Agents Chemother. 1999;43(6):1317–1323. doi:10.1128/AAC.43.6.1317
- Giacobbe DR, Saffioti C, Losito AR, et al. Use of colistin in adult patients: a cross-sectional study. J Glob Antimicrob Resist. 2020;20:43–49. doi:10.1016/j.jgar.2019.06.009
- Ezadi F, Ardebili A, Mirnejad R. Antimicrobial susceptibility testing for polymyxins: challenges, issues, and recommendations. J Clin Microbiol. 2019;57(4). doi:10.1128/JCM.01390-18
- Wanyne P. Clinical and Laboratory Standard Institute. Vol. M100. 29th ed. CLSI; 2019.
- Wayne P. Clinical Laboratory Standard Institute. Vol. M100. CLSI; 2020.
- Liu -Y-Y, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168. doi:10.1016/S1473-3099(15)00424-7
- Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012–2016). Clin Infect Dis. 2018;67(suppl_2):S196–S205. doi:10.1093/cid/ciy660
- Hameed F, Khan M; HB- … C& H. Detection of MCR-1 gene in multiple drug resistant Escherichia coli and Klebsiella pneumoniae in human clinical samples from Peshawar, Pakistan; 2021. ingentaconnect.com. Available from: https://www.ingentaconnect.com/content/ben/cchts/2021/00000024/00000005/art00011. Accessed July 30, 2022.
- Naylor NR, Pouwels KB, Hope R, et al. The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: a national retrospective cohort study. PLoS One. 2019;14(9):e0221944. doi:10.1371/journal.pone.0221944
- Peters L, Olson L, Khu DTK, et al. Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: a cohort study among neonatal intensive care patients with hospital-acquired infections caused by gram-negative bacteria in Vietnam. PLoS One. 2019;14(5):e0215666. doi:10.1371/journal.pone.0215666
- Zhou H, Zhang K, Chen W, et al. Epidemiological characteristics of carbapenem-resistant Enterobacteriaceae collected from 17 hospitals in Nanjing district of China. Antimicrob Resist Infect Control. 2020;9(1). doi:10.1186/S13756-019-0674-4
- Chen C-W, Tang H-J, Chen -C-C, et al. The microbiological characteristics of carbapenem-resistant Enterobacteriaceae carrying the mcr-1 gene. J Clin Med. 2019;8:261. doi:10.3390/jcm8020261
- Munoz-Price L, Poirel L; RB-TL Infectious. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases; 2013. Elsevier. Available from: https://www.sciencedirect.com/science/article/pii/S1473309913701907. Accessed March 13, 2022.
- Hayden M, Lin M, Lolans K; SW-CI. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase–producing Enterobacteriaceae in long-term acute-care hospitals; 2015. academic.oup.com. Available from: https://academic.oup.com/cid/article-abstract/60/8/1153/2462777. Accessed March 13, 2022.
- Thaden J, Lewis S, Hazen K; KH-IC&. Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of; 2014. cambridge.org. Available from: https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/rising-rates-of-carbapenemresistant-enterobacteriaceae-in-community-hospitals-a-mixedmethods-review-of-epidemiology-and-microbiology-practices-in-a-network-of-community-hospitals-in-the-southeastern-united-states/1E94FDE8AE9F631E92A329D7FACE591E. Accessed March 13, 2022.
- Bilal H, Tu R, Khan M, et al. Discovery of mcr-1 harboring Incl2 plasmids from clinical isolates of multiclonal E. coli prevalent in Pakistan; 2020. Available from: https://scholar.archive.org/work/r2khneqzfzfkxhwkh3cw3lm4hi/access/wayback/https://assets.researchsquare.com/files/rs-74913/v1/9822f58b-9654-4817-9b86-43f53d9d1301.pdf. Accessed March 13, 2022.
- Moosavian M; Resistance NE-I and Drug. The first report of emerging mobilized colistin-resistance (mcr) genes and ERIC-PCR typing in Escherichia coli and Klebsiella pneumoniae clinical isolates in; 2019. ncbi.nlm.nih.gov. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6500874/. Accessed March 13, 2022.
- Zhong L, Phan H, Shen C; KV-CI. High rates of human fecal carriage of mcr-1–positive multidrug-resistant Enterobacteriaceae emerge in china in association with successful plasmid families; 2018. academic.oup.com. Available from: https://academic.oup.com/cid/article-abstract/66/5/676/4430429. Accessed March 13, 2022.
- Eiamphungporn W, Yainoy S; CJ-J of Global. Prevalence of the colistin resistance gene mcr-1 in colistin-resistant Escherichia coli and Klebsiella pneumoniae isolated from humans in Thailand; 2018. Elsevier. Available from: https://www.sciencedirect.com/science/article/pii/S2213716518301176. Accessed March 13, 2022.
- Ling Z, Yin W, Shen Z, Wang Y, Shen J, Walsh TR. Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9. J Antimicrob Chemother. 2020;75(11):3087–3095. doi:10.1093/jac/dkaa205
- Wise MG, Estabrook MA, Sahm DF, Stone GG, Kazmierczak KM. Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014–2016 as part of the INFORM global surveillance program. PLoS One. 2018;13(4):e0195281. doi:10.1371/journal.pone.0195281
- Du H, Chen L, Tang YW, Kreiswirth BN. Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect Dis. 2016;16(3):287–288. doi:10.1016/S1473-3099(16)00056-6
- Huang H, Dong N, Shu L, et al. Colistin-resistance gene mcr in clinical carbapenem-resistant Enterobacteriaceae strains in China, 2014–2019. Emerg Microbes Infect. 2020;9(1):237–245. doi:10.1080/22221751.2020.1717380
- Jiang Y, Zhang Y, Lu J, et al. Clinical relevance and plasmid dynamics of mcr-1-positive Escherichia coli in China: a multicentre case-control and molecular epidemiological study. Lancet Microbe. 2020;1(1):e24–e33. doi:10.1016/S2666-5247(20)30001-X
- Saleem Z, Hassali MA, Godman B, Hashmi FK, Saleem F. A multicenter point prevalence survey of healthcare–associated infections in Pakistan: findings and implications. Elsevier. Available from: https://www.sciencedirect.com/science/article/pii/S0196655318309556. Accessed March 13, 2022.